The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Rapamycin in patients with advanced hepatocellular carcinoma progressing on prior antiangiogenic therapy.
Mohamed Bouattour
No relevant relationships to disclose
Johanna Wassermann
No relevant relationships to disclose
Chantal Dreyer
No relevant relationships to disclose
Valérie Vilgrain
No relevant relationships to disclose
Valerie Paradis
No relevant relationships to disclose
Eric Raymond
No relevant relationships to disclose
Sandrine J. Faivre
No relevant relationships to disclose